Sector performance

as of 6:51 AM ET 02/05/2026

Loading...

Latest sector news

HC Wainwright Initiates Incyte at Buy With $135 Price Target

6:38 AM ET 02/05/2026 - MT Newswires

06:38 AM EST, 02/05/2026 (MT Newswires) -- Incyte (INCY) has an average rating of overweight and mean price target of $105.43, according to analysts polled by FactSet. More

Prestige Consumer Fiscal Q3 Adjusted Earnings, Revenue Fall; Full-Year Outlook Revised 6:35 AM ET 02/05/2026 - MT Newswires
Mizuho Adjusts Price Target on UnitedHealth Group to $350 From $430, Maintains Outperform Rating 6:32 AM ET 02/05/2026 - MT Newswires
Earnings Flash (HAE) Haemonetics Posts Fiscal Q3 Adjusted EPS $1.31, vs. FactSet Est of $1.22 6:18 AM ET 02/05/2026 - MT Newswires
Cigna Q4 Adjusted Income, Revenue Rise; 2026 Outlook Set 6:18 AM ET 02/05/2026 - MT Newswires

Best and worst stocks in this sector

as of 6:51 AM ET 02/05/2026
Best-performing stocks
Symbol Name % change
SCLN Sciclone Pharmaceuticals,... 0.00%
ZLTQ Zeltiq Aesthetics, Inc. 0.00%
DSCI Derma Sciences, Inc. 0.00%
ETRM Null 0.00%
HH Hooper Holmes, Inc. 0.00%
KITE Kite Pharma, Inc. 0.00%
MATN Mateon Therapeutics, Inc. 0.00%
NDRM Neuroderm Ltd. - Ordinary... 0.00%
NWBO Northwest Biotherapeutics... 0.00%
OPXA Null 0.00%
Worst-performing stocks
Symbol Name % change
ADHD Alcobra Ltd –85.10%
BIOB Bio-rad Laboratories, Inc... –0.14%
DSCI Derma Sciences, Inc. 0.00%
ETRM Null 0.00%
HH Hooper Holmes, Inc. 0.00%
KITE Kite Pharma, Inc. 0.00%
MATN Mateon Therapeutics, Inc. 0.00%
NDRM Neuroderm Ltd. - Ordinary... 0.00%
NWBO Northwest Biotherapeutics... 0.00%
OPXA Null 0.00%